Company Renata PLC

RENATA

BD0457RENAT6

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-04-21 pm EDT			5-day change	1st Jan Change
783.1 ^BDT	+0.09%		-2.99%	-35.70%

Feb. 13	Renata Limited will Change its Name to Renata PLC	CI
Jan. 27	Renata Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Renata PLC, formerly Renata Limited, is a Bangladesh-based pharmaceutical and animal health company. The Company is engaged in manufacturing, marketing and distribution of pharmaceutical, animal health products, oncology-based products, agro-based products, poultry products, and consumer products. The Company also engages in the business as traders, importers, exporters, commission agents of all kinds of goods and services, including pharmaceutical drugs and medicines. Its offerings include Algin Injection, Algin Syrup, Alphapress Tablet, Androcap Capsule, Becosules Capsule, Bredicon Tablet, Cabolin Tablet, Anorexon Tablet, Aquastar Growout Powder, Avinex Powder, Catophos Injection, Eggshell Tmo Powder, Ectorid Injection, Doxivet Powder, Fevenil Injection, Fluximine Injection, Cardipin Tablet, Cartilage Plus Tablet, and Diadin Injection, among others.

Number of employees: 7,119

BDT in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical, Animal Health Products, Oncology-based Products, Agro-based Products, Poultry Products and Consumer Products 100.0 %	31,071	100.0 %	32,971	100.0 %	+6.12%

BDT in Million	2022	Weight	2023	Weight	Delta
Bangladesh 100.0 %	31,071	100.0 %	32,971	100.0 %	+6.12%

Managers	Title	Age	Since
Syed S. Kaiser Kabir CEO	Chief Executive Officer	-	01-12-31
Khokan Chandra Das DFI	Director of Finance/CFO	-	-
Rakibul Mohammed Huq CTO	Chief Tech/Sci/R&D Officer	-	10-05-31
Mohammed S. Rahman Bhuiyan SAM	Sales & Marketing	-	-
Zaki Chowdhury LAW	General Counsel	-	07-12-31
Nisbat Anwar HRO	Human Resources Officer	-	-
A. T. M. Muniruzzaman AUD	Comptroller/Controller/Auditor	-	-
Monowarul Islam PRN	Corporate Officer/Principal	-	02-12-31
Sayma Ali PRN	Corporate Officer/Principal	-	-
Mohammad Jubayer Alam SEC	Corporate Secretary	-	02-12-31

Members of the board	Title	Age	Since
Syed S. Kaiser Kabir CEO	Chief Executive Officer	-	01-12-31
Sarwar Ali CHM	Chairman	82	93-12-31
Zahida Fizza Kabir BRD	Director/Board Member	-	13-08-26
Tanya Tazeem Karim BRD	Director/Board Member	-	-
Nehal Ahmed BRD	Director/Board Member	-	-
Sajeda Farisa Kabir BRD	Director/Board Member	-	-
Mridul Chowdhury BRD	Director/Board Member	-	-
Ejaj Ahmad BRD	Director/Board Member	-	19-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	114,696,490	17,385,250 ( 15.16 %)	0	15.16 %

Name	Equities	%	Valuation
Sajida Foundation 51.09 %	58,598,500	51.09 %	409 M BDT
Business Research International Corp., Inc. 21.61 %	24,787,762	21.61 %	173 M BDT
Shadharan Bima Corp. 4.141 %	4,749,347	4.141 %	33 M BDT
ICB Asset Management Co. Ltd. 3.395 %	3,894,016	3.395 %	27 M BDT
INVESTMENT CORPORATION OF BANGLADESH 2.911 %	3,338,984	2.911 %	23 M BDT
Syed S. Kaiser Kabir 0.1386 %	158,923	0.1386 %	1 M BDT
Tundra Fonder AB 0.0251 %	28,750	0.0251 %	200 870 BDT
Eurizon Capital SA 0.0180 %	20,645	0.0180 %	144 242 BDT
DFP Deutsche Finanz Portfolioverwaltung GmbH 0.0137 %	15,747	0.0137 %	110 021 BDT

Renata Plc

Plot No. 1 Milk Vita Road

1216, Dhaka

+880 2 800 1450

http://www.renata-ltd.com

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

783.1 BDT

Average target price

1,109 BDT

Spread / Average Target

+41.62%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
RENATA PLC	-35.70%	818M
ELI LILLY AND COMPANY	+25.46%	659B
NOVO NORDISK A/S	+26.69%	557B
JOHNSON & JOHNSON	-4.86%	359B
MERCK & CO., INC.	+16.44%	322B
ABBVIE INC.	+8.34%	297B
ASTRAZENECA PLC	+6.34%	215B
NOVARTIS AG	+7.69%	210B
ROCHE HOLDING AG	-6.22%	200B
PFIZER, INC.	-8.79%	149B

Other Pharmaceuticals